Researchers are working on developing blood tests that can detect breast cancer markers before a tumor becomes visible on imaging. These tests, often referred to as "liquid biopsies," seek to find circulating tumor DNA (ctDNA) or other biomarkers in a patient's blood. Early detection through minimally invasive means could significantly improve treatment outcomes.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.